Industry Podcast
4 Aug 2025
August Bio: Strategic Guide to CDMO Scale-Up
Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.
Content provided by our supplier
August Bioservices
-
Country/Region:United States
-
On CPHI since:2021
-
Certificates:2
-
Employees:50 - 99
Company types
Primary activities
Other Content from August Bioservices (3)
-
Brochure August Bioservices Capabilities
Welcome to August Bioservices At August Bioservices, we are a US-based, world-class CDMO specializing in sterile injectable drug development and manufacturing. With a full spectrum of capabilities from early-stage formulation to commercial production, we partner with clients to bring life-changing therapies to patients faster. Our team of industry experts, cutting-edge technology, and flexible, scalable solutions are built to meet your product’s unique needs at every stage. -
Video Time Lapse Video of New August Bio Facility Expansion
Watch as 12 months of construction unfolds before your eyes in 30 seconds.
The facility expansion shown here is adding to August Bioservices' Nashville, TN, USA campus:
- 3 new formulation suites
- 2 new filling suites for high-speed vial and PFS lines
- significant warehousing capacity
- redundant utilities
- multi-bay loading dock
-
Video New Facility Announcement - Additional high-speed IV bag, syringe and vial lines with exceptional manufacturing flexibility
August Bioservices, a US-based CDMO, is expanding its current facility and is building a new facility immediately adjacent to its existing building that will house drug discovery, development, formulation, scale up, analytical testing, and clinical and commercial manufacturing - all "under one roof", on one contiguous campus in Nashville, TN.
With a strong focus on sterile injectables and decades of commercialization experience across the leadership team, August Bioservices' manufacturing capabilities can handle a wide range of container sizes and fill volumes.
Vials - 1/2 mL to 500 mL
Bags - 25 mL to 5 L
Syringes - 1/4 mL to 50 mL
As can be seen in this video, August's growth initiatives continue to receive exceptional support from all levels of government and industry in the state of TN.